Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

New neuromuscular blocking drugs

Article Abstract:

Pharmaceutical companies have yet to devise a neuromuscular blocking drug that takes effect quickly, lasts a fairly long time, has few side effects and is rapidly secreted by the body. Neuromuscular blocking drugs act by blocking the nerve impulse that makes a muscle contract. Several drugs have been developed for different types of medical interventions, including tracheal intubation, surgery, mechanical ventilation and treatment of burn patients. Because the drugs can affect other neurotransmitter receptors, they can affect the heart and other organs. They should be used with special care in infants and the elderly and in patients with kidney, liver, heart and neuromuscular diseases.

Author: Hunter, Jennifer M.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995
Physiological aspects, Neuromuscular blocking agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Myocardial bridging in children with hypertrophic cardiomyopathy - a risk factor for sudden death

Article Abstract:

Myocardial bridging can be a serious complication of hypertrophic cardiomyopathy in children. Hypertrophic cardiomyopathy is a heart disease characterized by an enlarged heart. Myocardial bridging occurs when the enlarged heart compresses one of the coronary arteries. In a study of 36 children with hypertrophic cardiomyopathy, 28% experienced myocardial bridging. These children were more likely to have chest pain, cardiac arrest, severe arrhythmias, and inability to exercise for long periods of time. They also had lower five-year survival rates.

Author: MacDonald, Cathy, McCrindle, Brian W., Freedom, Robert M., Yetman, Anji T., Gow, Robert
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Cardiomyopathy, Hypertrophic, Sudden death, Hypertrophic cardiomyopathy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Class of antiretroviral drugs and the risk of myocardial infarction

Article Abstract:

Study reveals that longer exposure to protease inhibitors increases the risk of myocardial infarction in patients however no association was found between use of nonnucleoside reverse-transcriptase inhibitors and risk of myocardial infarction.

Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2007
Heart attack, Antiviral agents, Antiretroviral agents, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Complications and side effects, Risk factors
Similar abstracts:
  • Abstracts: Injury prevention in primary care. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study
  • Abstracts: Mutations of the growth hormone receptor in children with idiopathic short stature. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation
  • Abstracts: Special siblings. Support for children with special needs. Get spinning child's family biking special
  • Abstracts: Prevalence and determinants of prone sleeping position in infants: results from two cross-sectional studies on risk factors for SIDS in Germany
  • Abstracts: Forgiveness and health: An act of healing. Pet loss and grief: coping with the pain. Healing grief: Dealing with loss
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.